That has been undone now, though.

y-curious 4 hours ago | parent | next [-]

Section 174 as it stands means R&D costs companies less, not more. It would be bullish for the SWE profession. It’s still around

Has it? I haven’t seen anything about that.

	▲	stock_toaster 3 hours ago \| parent [-]
		I thought it was mostly rolled back for domestic R&D as part of the terribly named OBBBA. [1]: found a ref https://www.bnncpa.com/resources/one-big-beautiful-bill-act-...